Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.

Ann Rheum Dis · 2022 · PMC9606512 · PMID 35914929

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp=0.08so close (0.05 < p ≤ 0.1)

Self-reported disease outcomes, as measured by SF-36, showed a trend towards improvement with PGZ that was not statistically significant (p=0.08).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.